{"DataElement":{"publicId":"2505658","version":"1","preferredName":"Cytomorphology Masood Risk Assessment Number","preferredDefinition":"The number used to represent the raw masood score.","longName":"CYTOM_MASOOD_ASS_NUM","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2407179","version":"1","preferredName":"Breast Cancer Masood Cytology Risk Assessment","preferredDefinition":"Masood Cytology Index to stratify rpFNA speciments for the degree cytologic abnormalities.","longName":"BRST_CA_MASOOD_ASSES","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2407176","version":"1","preferredName":"Breast Malignant Neoplasm Risk Assessment","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.","longName":"C12971:C9305:C15367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Health Risk Assessment","conceptCode":"C15367","definition":"An estimated probability that one or more adverse event(s) will occur as a result of exposure to an actual or potential hazardous situation or chemical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-4A38-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-22","modifiedBy":"ONEDATA","dateModified":"2005-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2407177","version":"1","preferredName":"Cytology Assessment","preferredDefinition":"Cytology; the branch of biology that studies the structure and function of cells.:Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber's)","longName":"C16491:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytology","conceptCode":"C16491","definition":"The light microscopic study of normal and abnormal cells in fine needle aspirates (FNAs), body cavity fluids, and smears.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-4A3C-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-22","modifiedBy":"ONEDATA","dateModified":"2005-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-4A3D-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2505655","version":"1","preferredName":"Cytomorphology Masood Risk Assessment Number","preferredDefinition":"The number used to represent the raw masood score.","longName":"CYTOM_MASOOD_ASS_NUM","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233101","version":"1","preferredName":"Number","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F920A342-1134-2A6A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1ABF5406-4584-0877-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-11","modifiedBy":"MAESKEB","dateModified":"2006-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812190","version":"1","longName":"Acolbifene - High Risk for Breast Cancer","context":"DCP"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"CYTOM_MASOOD_ASS_NUM","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Masood Score","type":"Preferred Question Text","description":"Masood Score","url":null,"context":"DCP"},{"name":"DCP Document Text 2","type":"Alternate Question Text","description":"Masood Score Result","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1ABF5952-CF3C-09E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-11","modifiedBy":"FORMBUILDER","dateModified":"2014-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}